On April 4, Mr. Liu launched a clinical trial of naltrexone implant at Hunan Provincial Brain Hospital.
He is the first patient in China to implant n saltrexone for alcohol addiction. According to a survey, the prevalence of alcohol and drug use disorder in China is 1.94%. Excessive alcohol consumption can lead to gastrointestinal ulcers, liver damage, peripheral neuritis, cardiovascular diseases and other diseases, but also traffic accidents, crime, child abuse, domestic violence and various forms of injury.